Asapharm SRL
The score of Asapharm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +251 % Total assets +48 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Asapharm's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 11 Jul 2025
- Year ended 31 Dec 2023filed on 18 Jul 2024
- Year ended 31 Dec 2022filed on 28 Jun 2023
- Year ended 31 Dec 2021filed on 20 Jul 2022
Asapharm's financial analysis
- Solvency8.6%sector median: 40.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Asapharm
Asapharm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0645.733.354
- VAT number
- BE0645733354
- Peppol
- Registered · 0208:0645733354 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 Jan 2016
- Registered office
- 5031 Gembloux
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Asapharm (SRL) has been based in Gembloux since 2016, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 139,678 € and equity of 160,138 €; its revenue is not published. Its solvency stands at 8.6%, below the median of its sector (40.1%).
Companies similar to Asapharm
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Apotheek Kortessem Retail sale of pharmaceutical products Hasselt · balance sheet €1.86m
- Fayser Retail sale of pharmaceutical products Pont-à-Celles · balance sheet €1.85m
- Delputte Marie SRL Retail sale of pharmaceutical products Awans · balance sheet €1.85m
- Pharma Officinalis Retail sale of pharmaceutical products Ternat · balance sheet €1.83m
- JUVO Retail sale of pharmaceutical products Oudenburg · balance sheet €1.89m
- SikaCare Retail sale of pharmaceutical products Hasselt · balance sheet €1.82m
- Kevin BULKMANS Retail sale of pharmaceutical products Temse · balance sheet €1.93m
Frequently asked questions about Asapharm
What is the revenue of Asapharm?
Asapharm files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Asapharm?
In Belgium, the VAT number is the company number prefixed with BE: BE0645733354 for Asapharm, if the company is VAT-registered. Its company number (CBE) is 0645.733.354.
Where is the registered office of Asapharm?
According to the CBE register, the registered office of Asapharm is in 5031 Gembloux.
What is the equity of Asapharm?
At the close of the 2025 financial year, the equity of Asapharm amounts to 160,138 €, a solvency of 8.6% of total assets.
Who manages Asapharm?
The register lists 1 active mandates at Asapharm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Asapharm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →